BIORETEC OY Market Cap ($16.10 Million)
Market Cap & Net Worth: BIORETEC OY (0TN)
BIORETEC OY market cap. BIORETEC OY (F:0TN) has a market capitalization of $16.10 Million (€13.77 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #25617 globally and #2194 in its home market, demonstrating a 20.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BIORETEC OY's stock price €0.02 by its total outstanding shares 1341785963 (1.34 Billion). Also see 0TN cash flow metrics for how efficiently the company converts equity into cash flow.
BIORETEC OY Market Cap History (2021–2026)
BIORETEC OY market cap history from 2021 to 2026. Data shows change from $4.36 Billion to $30.12 Million (-63.11% CAGR). Check 0TN stock price and chart for real-time trading data and today's change.
BIORETEC OY Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BIORETEC OY's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore BIORETEC OY (0TN) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
260.14x
BIORETEC OY's market cap is 260.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $4.36 Billion | $2.00 Million | -$6.02 Million | 2177.31x | N/A |
| 2022 | $2.09 Billion | $2.94 Million | -$2.42 Million | 709.18x | N/A |
| 2023 | $3.61 Billion | $3.91 Million | -$3.79 Million | 923.66x | N/A |
| 2024 | $3.51 Billion | $4.54 Million | -$4.61 Million | 773.36x | N/A |
| 2025 | $916.11 Million | $3.52 Million | -$9.48 Million | 260.14x | N/A |
Competitor Companies of 0TN by Market Capitalization
Companies near BIORETEC OY in the global market cap rankings as of November 4, 2026. Also see 0TN asset base for a full breakdown of the balance sheet.
Key companies related to BIORETEC OY by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of BIORETEC OY (2021–2026)
Market capitalization of BIORETEC OY from 2021 to today. Between 2021 and today, BIORETEC OY's market cap moved from $4.36 Billion to $ 30.12 Million, with a yearly change of -63.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €30.12 Million | -96.71% |
| 2025 | €916.11 Million | -73.93% |
| 2024 | €3.51 Billion | -2.61% |
| 2023 | €3.61 Billion | +72.93% |
| 2022 | €2.09 Billion | -52.16% |
| 2021 | €4.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of BIORETEC OY was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.10 Million USD |
| MoneyControl | $16.10 Million USD |
| MarketWatch | $16.10 Million USD |
| marketcap.company | $16.10 Million USD |
| Reuters | $16.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more